Weight-loss injection (Abnehmspritze)
Weight-loss injections such as semaglutide or tirzepatide mimic satiety hormones. In obesity they work noticeably – but usually only as long as you take them.
Ausführlich erklärt
“Abnehmspritze” (weight-loss injection) is the everyday name for medicines that act like the gut hormone GLP-1: semaglutide (Wegovy) and tirzepatide (Mounjaro), which also mimics the hormone GIP. They dampen appetite and make you feel full sooner; the injection is given once a week. Since 1 September 2026, semaglutide has also been available as a tablet in Germany.
How much do they achieve? In the approval studies, adults lost on average almost 15% of their body weight in about 16 months with semaglutide and up to 21% with the highest dose of tirzepatide – with a placebo it was 2 to 3%. The drugs are approved for adults with a BMI of 30 or more, or a BMI of 27 or more with a weight-related health condition, always in addition to diet and exercise. Semaglutide injections are also approved for teenagers aged 12 and over with obesity who weigh more than 60 kg, in that case under specialist medical supervision.
What should you know? Common side effects are nausea, vomiting, diarrhea, constipation and stomach pain. Along with fat, you also lose muscle – strength training and enough protein help preserve it. After stopping, weight often comes back: in one study, about two thirds of the loss was back a year later.
Statutory health insurance in Germany does not pay for weight-loss medicines (§ 34 SGB V, as of November 2026); depending on the drug and dose, treatment costs roughly €170 to €500 a month. Never buy these drugs online without a prescription: insulin has already been found in counterfeit pens. Whether a medicine is an option for you is something to discuss with your doctor.